SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RT who wrote (2383)11/11/1997 7:20:00 PM
From: BigKNY3  Read Replies (2) of 23519
 
Frostman <<Since Pfizer has already started a media blitz a minimum of 6 months prior to the release of Viagra what do you think they'll do when they actually have a product to sell. We haven't seen nothing yet.>>

Frost: I know you may find this difficult to believe, but Pfizer is not behind the current publicity concerning ED. Newspapers, journals and television news shows are generating this news by themselves. According to FDA regulations, no pharmaceutical company can promote or PR a pharmaceutical product until final labeling and indications are approved. Pfizer is smart enough to know not to jeopardize Viagra's review by violating these well-known FDA regulations. The Newsweek article noted that Pfizer would not comment on the product until approval is received.

BigKNY3
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext